Selecta Trio - Retinal, Cataract and Glaucoma Therapy in One

The Selecta Trio has all of the advantages of the Selecta Duet in SLT and YAG modes – along with proprietary advantages in photocoagulation mode

The Lumenis Selecta® Trio™ represents the next generation of multi-modality products, offering retinal, cataract and advanced glaucoma therapies in a single platform. The unit’s integrated design, enhanced optics system and advanced laser cavity make the Trio one of the highest performing laser products in the market – maximum flexibility with minimum footprint.

The Lumenis Selecta Trio offers all the great benefits of the Lumenis Selecta Duet with the addition of the Lumenis Novus Spectra retinal laser making it a truly unique laser and perfect for multi-specialty clinics.

SmartV for Floaters

SmartV enables on-axis and off-axis illumination of both anterior and posterior vitreous opacities. 

Super Gaussian Beam Profile in YAG Mode

The smart Selecta Duet features a highly accurate Super Gaussian beam profile in order to achieve optical breakdown – or photo disruption – with the lowest possible energy levels.


Advanced Adjustable Offset

The Selecta features 3 posterior defocus positions with an adjustable focal point of up to 350 μm posterior to the aiming beam.


Homogeneous Laser Beam

Our advanced optics and laser delivery technology features uniform energy distribution across the entire laser spot area for more precise and safer treatments. The result is homogenous laser spot with evenly distributed power across the full area of the spot, eliminating the potential risk for the formation of “hot spots”.

Dual Fiber Port

Instantly switch between delivery devices. Changing delivery devices is fast and easy. The Selecta Trio automatically senses the delivery devices connected to it. Laser parameters are adjusted internally to  compensate for the chosen delivery device to maintain selected power density on the target tissue.

ClearView™ Filters

Optimized view of treatment site the Lumenis ClearView™ filters’ photopic balanced coating eliminates colour distortion of the treatment site while optimizing white light transmission or “brightness” of the physician’s view. A proprietary coating protects the filter from environmental changes and scratches.

SureSpot™ Optics

The unique and patented SureSpot optics technology from Lumenis ensures that the focal point of the laser beam is maintained on the retina while power density on the cornea and lens is minimized for increased safety.

SureSpot optics also creates a true 50-micron laser spot; that capability distinguishes the Lumenis technology from other lasers that may have a 100-micron minimum spot size and/or project a fuzzy laser spot on the retina.

In essence, SureSpot optics improves treatment efficacy and precision while reducing the potential for damage to anterior-segment tissues. The latter occurrence is especially a concern when using wide-angle lenses that enhance light uptake by the cornea and lens.

We use SLT as first line therapy in just about every patient that comes in and who’s a good patient, so we offer SLT as primary therapy and I think this is probably the most  important role that SLT has played in the management of Glaucoma

Mark A. Latina, MD

Lumenis Selecta Brochure


SLT Success Predictor


Lumenis Selecta Specifications



Related Products